Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementing Geriatric Assessment for Dose Optimization of CDK 4/6-inhibitors in Older Breast Cancer Patients - a Pragmatic Randomized-controlled Trial (IMPORTANT Trial)

NCT06044623 is registered in ClinicalTrials.gov with Region Örebro County as lead sponsor.

NCT NCT06044623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06044623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementing Geriatric Assessment for Dose Optimization of CDK 4/6-inhibitors in Older Breast Cancer Patients - a Pragmatic Randomized-controlled Trial (IMPORTANT Trial)
Lead sponsor
Region Örebro County
Phase
Phase 3
Overall status
Recruiting
Start date
April 1, 2024
Completion date
May 31, 2029
Enrollment
495 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

advanced breast cancer, metastatic breast cancer, older patients, quality of life, toxicity